Abiopharma

New Form 10-Q - MoonLake Immunotherapeutics Filed: 2025-08-05 AccNo: 0001821586-25-000018 Size: 7 MB

New Form 8-K - Orthofix Medical Inc. Filed: 2025-08-05 AccNo: 0000950170-25-102383 Size: 18 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - Axogen, Inc. Filed: 2025-08-05 AccNo: 0000805928-25-000104 Size: 2 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - MoonLake Immunotherapeutics Filed: 2025-08-05 AccNo: 0001821586-25-000016 Size: 285 KB Item 2.02: Results of Operations and Financial Condition

New Form 10-Q - Pediatrix Medical Group, Inc. Filed: 2025-08-05 AccNo: 0000950170-25-102382 Size: 6 MB

New Form 6-K - AC Immune SA Filed: 2025-08-05 AccNo: 0001558370-25-010174 Size: 5 MB

New Form 8-K - Pediatrix Medical Group, Inc. Filed: 2025-08-05 AccNo: 0000950170-25-102375 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 8-K - Azenta, Inc. Filed: 2025-08-05 AccNo: 0001437749-25-024705 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 10-Q - Vigil Neuroscience, Inc. Filed: 2025-08-05 AccNo: 0000950170-25-102371 Size: 8 MB

New Form 8-K - Shattuck Labs, Inc. Filed: 2025-08-05 AccNo: 0001193125-25-173010 Size: 842 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits